BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28960210)

  • 1. The effects of oxytocin on eating behaviour and metabolism in humans.
    Lawson EA
    Nat Rev Endocrinol; 2017 Dec; 13(12):700-709. PubMed ID: 28960210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin's inhibitory effect on food intake is stronger in obese than normal-weight men.
    Thienel M; Fritsche A; Heinrichs M; Peter A; Ewers M; Lehnert H; Born J; Hallschmid M
    Int J Obes (Lond); 2016 Nov; 40(11):1707-1714. PubMed ID: 27553712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys.
    Blevins JE; Graham JL; Morton GJ; Bales KL; Schwartz MW; Baskin DG; Havel PJ
    Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R431-8. PubMed ID: 25540103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin reduces caloric intake in men.
    Lawson EA; Marengi DA; DeSanti RL; Holmes TM; Schoenfeld DA; Tolley CJ
    Obesity (Silver Spring); 2015 May; 23(5):950-6. PubMed ID: 25865294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans.
    Kerem L; Lawson EA
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current findings on the role of oxytocin in the regulation of food intake.
    Spetter MS; Hallschmid M
    Physiol Behav; 2017 Jul; 176():31-39. PubMed ID: 28284882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Oxytocin for Obesity.
    Plessow F; Kerem L; Wronski ML; Asanza E; O'Donoghue ML; Stanford FC; Eddy KT; Holmes TM; Misra M; Thomas JJ; Galbiati F; Muhammed M; Sella AC; Hauser K; Smith SE; Holman K; Gydus J; Aulinas A; Vangel M; Healy B; Kheterpal A; Torriani M; Holsen LM; Bredella MA; Lawson EA
    NEJM Evid; 2024 May; 3(5):EVIDoa2300349. PubMed ID: 38815173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An obligate role of oxytocin neurons in diet induced energy expenditure.
    Wu Z; Xu Y; Zhu Y; Sutton AK; Zhao R; Lowell BB; Olson DP; Tong Q
    PLoS One; 2012; 7(9):e45167. PubMed ID: 23028821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin, eating behavior, and metabolism in humans.
    Kerem L; Lawson EA
    Handb Clin Neurol; 2021; 180():89-103. PubMed ID: 34225952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coming full circle: contributions of central and peripheral oxytocin actions to energy balance.
    Ho JM; Blevins JE
    Endocrinology; 2013 Feb; 154(2):589-96. PubMed ID: 23270805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment.
    Zhang G; Cai D
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E1004-12. PubMed ID: 21828335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin reduces reward-driven food intake in humans.
    Ott V; Finlayson G; Lehnert H; Heitmann B; Heinrichs M; Born J; Hallschmid M
    Diabetes; 2013 Oct; 62(10):3418-25. PubMed ID: 23835346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin as a potential pharmacological tool to combat obesity.
    Olszewski PK; Noble EE; Paiva L; Ueta Y; Blevins JE
    J Neuroendocrinol; 2022 Sep; 34(9):e13106. PubMed ID: 35192207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin and potential benefits for obesity treatment.
    Olszewski PK; Klockars A; Levine AS
    Curr Opin Endocrinol Diabetes Obes; 2017 Oct; 24(5):320-325. PubMed ID: 28590323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin and Vasopressin Systems in Obesity and Metabolic Health: Mechanisms and Perspectives.
    Ding C; Magkos F
    Curr Obes Rep; 2019 Sep; 8(3):301-316. PubMed ID: 31240613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational and therapeutic potential of oxytocin as an anti-obesity strategy: Insights from rodents, nonhuman primates and humans.
    Blevins JE; Baskin DG
    Physiol Behav; 2015 Dec; 152(Pt B):438-49. PubMed ID: 26013577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
    Jbilo O; Ravinet-Trillou C; Arnone M; Buisson I; Bribes E; Péleraux A; Pénarier G; Soubrié P; Le Fur G; Galiègue S; Casellas P
    FASEB J; 2005 Sep; 19(11):1567-9. PubMed ID: 16009704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous overfeeding with a 'cafeteria diet' in men: effects on 24-hour energy expenditure and substrate oxidation.
    Larson DE; Rising R; Ferraro RT; Ravussin E
    Int J Obes Relat Metab Disord; 1995 May; 19(5):331-7. PubMed ID: 7647825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior.
    Olszewski PK; Klockars A; Schiöth HB; Levine AS
    Pharmacol Biochem Behav; 2010 Nov; 97(1):47-54. PubMed ID: 20595062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between oxytocin, dietary intake and feeding: A systematic review and meta-analysis of studies in mice and rats.
    Skinner JA; Campbell EJ; Dayas CV; Garg ML; Burrows TL
    Front Neuroendocrinol; 2019 Jan; 52():65-78. PubMed ID: 30315826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.